Parental ADHD in pregnancy and the postpartum period – A systematic review

[1]  Widya Risnawaty,et al.  PENGUJIAN RELIABILITAS ALAT UKUR THE PARENTING STYLES AND DIMENSION QUESTIONNAIRE (PSDQ) , 2021 .

[2]  A. Carvalho,et al.  Environmental risk factors, protective factors, and peripheral biomarkers for ADHD: an umbrella review. , 2020, The lancet. Psychiatry.

[3]  B. D’Onofrio,et al.  Associations of Prescribed ADHD Medication in Pregnancy with Pregnancy-Related and Offspring Outcomes: A Systematic Review , 2020, CNS Drugs.

[4]  T. Banaschewski,et al.  [Attention deficit hyperactivity disorder in childhood and adolescence : Current state of research]. , 2020, Der Nervenarzt.

[5]  S. Hinshaw,et al.  Adolescent Mediators of Unplanned Pregnancy among Women with and without Childhood ADHD , 2020, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53.

[6]  S. Visser,et al.  ADHD Medication Use During Pregnancy and Risk for Selected Birth Defects: National Birth Defects Prevention Study, 1998-2011 , 2020, Journal of attention disorders.

[7]  P. Damkier,et al.  First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations. , 2020, JAMA.

[8]  M. Hathcock,et al.  Amphetamine–Dextroamphetamine and Pregnancy: Neonatal Outcomes After Prenatal Prescription Mixed Amphetamine Exposure , 2020, Journal of attention disorders.

[9]  C. Nelson,et al.  Effects of Maternal Psychopathology and Education Level on Neurocognitive Development in Infants of Adolescent Mothers Living in Poverty in Brazil , 2019, Biological psychiatry. Cognitive neuroscience and neuroimaging.

[10]  E. Harvey,et al.  A Longitudinal Study of the Relation Between Family Functioning and Preschool ADHD Symptoms , 2019, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53.

[11]  D. Svikis,et al.  Associations Between ADHD Symptoms and Occupational, Interpersonal, and Daily Life Impairments Among Pregnant Women , 2019, Journal of attention disorders.

[12]  Z. Landau,et al.  Attention Deficit/Hyperactivity, the Metabolic Syndrome, and Type 2 Diabetes , 2019, Current Diabetes Reports.

[13]  G. Davey Smith,et al.  Association of Maternal Neurodevelopmental Risk Alleles With Early-Life Exposures , 2019, JAMA psychiatry.

[14]  Hai-yin Jiang,et al.  Maternal and neonatal outcomes after exposure to ADHD medication during pregnancy: A systematic review and meta‐analysis , 2018, Pharmacoepidemiology and drug safety.

[15]  S. Kittel-Schneider,et al.  The role of pre-, peri-, and postnatal risk factors in bipolar disorder and adult ADHD , 2019, Journal of neural transmission.

[16]  S. Kittel-Schneider,et al.  Genetic risk factors and gene–environment interactions in adult and childhood attention-deficit/hyperactivity disorder , 2019, Psychiatric genetics.

[17]  T. Hale,et al.  Evaluating Transfer of Modafinil Into Human Milk During Lactation: A Case Report. , 2018, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[18]  E. Simonsen,et al.  Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical look , 2018, BMJ Evidence-Based Medicine.

[19]  J. Nicholson,et al.  Maternal postnatal mental health and offspring symptoms of ADHD at 8–9 years: pathways via parenting behavior , 2018, European Child & Adolescent Psychiatry.

[20]  S. Dalsgaard,et al.  Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study , 2018, PloS one.

[21]  M. Freeman,et al.  Management of Attention Deficit Hyperactivity Disorder During Pregnancy. , 2018, Obstetrics and gynecology clinics of North America.

[22]  S. Faraone,et al.  Genetics of attention deficit hyperactivity disorder , 2018, Molecular Psychiatry.

[23]  E. Ferreira,et al.  Infant Exposure to Methylphenidate and Duloxetine During Lactation. , 2018, Breastfeeding Medicine.

[24]  D. Svikis,et al.  Attention-deficit/hyperactivity disorder symptom clusters differentially predict prenatal health behaviors in pregnant women. , 2018, Journal of clinical psychology.

[25]  B. Armstrong,et al.  Perinatal Outcomes of Women Diagnosed with Attention-Deficit/Hyperactivity Disorder: An Australian Population-Based Cohort Study , 2018, CNS Drugs.

[26]  P. Anderson.  Treating Hypertension During Breastfeeding. , 2018, Breastfeeding Medicine.

[27]  A. Ornoy.  Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation , 2018, Pharmaceutical Research.

[28]  E. Nøhr,et al.  Maternal body mass index before pregnancy as a risk factor for ADHD and autism in children , 2018, European Child & Adolescent Psychiatry.

[29]  S. Farr,et al.  Attention-Deficit/Hyperactivity Disorder Medication Prescription Claims Among Privately Insured Women Aged 15–44 Years — United States, 2003–2015 , 2018, MMWR. Morbidity and mortality weekly report.

[30]  A. Winterstein,et al.  Prevalence of ADHD in Publicly Insured Adults , 2018, Journal of attention disorders.

[31]  S. Hernández-Díaz,et al.  Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium , 2017, JAMA psychiatry.

[32]  B. Winbladh,et al.  Perinatal Outcomes After Treatment With ADHD Medication During Pregnancy , 2017, Pediatrics.

[33]  S. Hernández-Díaz,et al.  Placental Complications Associated With Psychostimulant Use in Pregnancy. , 2017, Obstetrics and gynecology.

[34]  Y. Bonomo,et al.  Two Case Studies Illustrating a Shared Decision-Making Approach to Illicit Methamphetamine Use and Breastfeeding. , 2017, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

[35]  D. Chateau,et al.  Psychotropic Drug Use before, during, and after Pregnancy: A Population-Based Study in a Canadian Cohort (2001-2013) , 2017, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[36]  E. Harvey,et al.  Mediators and Moderators of the Relation between Parental ADHD Symptomatology and the Early Development of Child ADHD and ODD Symptoms , 2016, Journal of Abnormal Child Psychology.

[37]  C. Begley,et al.  Bipolar disorder in pregnancy and childbirth: a systematic review of outcomes , 2016, BMC Pregnancy and Childbirth.

[38]  P. Grof,et al.  Early parent–child relationships and risk of mood disorder in a Canadian sample of offspring of a parent with bipolar disorder: findings from a 16‐year prospective cohort study , 2016, Early intervention in psychiatry.

[39]  A. Ornoy,et al.  Methylphenidate in Pregnancy: A Multicenter, Prospective, Comparative, Observational Study. , 2016, The Journal of clinical psychiatry.

[40]  R. Kitsommart,et al.  Transfer of Methamphetamine (MA) into Breast Milk and Urine of Postpartum Women who Smoked MA Tablets during Pregnancy , 2016, Journal of human lactation : official journal of International Lactation Consultant Association.

[41]  C. Hollis,et al.  The challenges of implementing ADHD clinical guidelines and research best evidence in routine clinical care settings: Delphi survey and mixed-methods study , 2016, BJPsych open.

[42]  Laura E. Brumariu.  Parent-Child Attachment and Emotion Regulation. , 2015, New directions for child and adolescent development.

[43]  O. Beck,et al.  Narcolepsy Treated with Racemic Amphetamine during Pregnancy and Breastfeeding , 2015, Journal of human lactation : official journal of International Lactation Consultant Association.

[44]  Cassandra N. Spracklen,et al.  Effects of smoking and preeclampsia on birth weight for gestational age , 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[45]  S. Vigod,et al.  Perinatal outcomes among women with bipolar disorder: a population-based cohort study. , 2015, American journal of obstetrics and gynecology.

[46]  J. Olsen,et al.  Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy , 2015, Clinical epidemiology.

[47]  A. Sjölander,et al.  Maternal age at childbirth and risk for ADHD in offspring: a population-based cohort study. , 2014, International journal of epidemiology.

[48]  A. Hansen,et al.  Use of ADHD medication during pregnancy from 1999 to 2010: a Danish register‐based study , 2014, Pharmacoepidemiology and drug safety.

[49]  J. Gosden,et al.  Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats , 2014, Journal of psychopharmacology.

[50]  J. Hallas,et al.  First-trimester exposure to methylphenidate: a population-based cohort study. , 2014, The Journal of clinical psychiatry.

[51]  B. Bolea-Alamanac,et al.  Methylphenidate use in pregnancy and lactation: a systematic review of evidence , 2014, British journal of clinical pharmacology.

[52]  B. Källén,et al.  The Use of Central Nervous System Active Drugs During Pregnancy , 2013, Pharmaceuticals.

[53]  J. Buitelaar,et al.  Match or Mismatch? Influence of Parental and Offspring ASD and ADHD Symptoms on the Parent–Child Relationship , 2013, Journal of autism and developmental disorders.

[54]  J. Buitelaar,et al.  Are parental autism spectrum disorder and/or attention-deficit/Hyperactivity disorder symptoms related to parenting styles in families with ASD (+ADHD) affected children? , 2013, European Child & Adolescent Psychiatry.

[55]  M. Liechti,et al.  Pharmacological characterization of designer cathinones in vitro , 2013, British journal of pharmacology.

[56]  J. Rosenbaum,et al.  Psychopathology in adolescent offspring of parents with panic disorder, major depression, or both: a 10-year follow-up. , 2012, The American journal of psychiatry.

[57]  M. Papoušek.  From the Start: Integration of Affect and Language in Parent-Infant Interactions: Commentary to Kubicek and EMDE, Emotional Expression and Language: A Longitudinal Study of Typically Developing Earlier and Later Talkers from 15 to 30 Months. , 2012, Infant mental health journal.

[58]  V. Lehti,et al.  Childhood predictors of becoming a teenage mother among Finnish girls , 2012, Acta obstetricia et gynecologica Scandinavica.

[59]  M. Reith,et al.  The Atypical Stimulant and Nootropic Modafinil Interacts with the Dopamine Transporter in a Different Manner than Classical Cocaine-Like Inhibitors , 2011, PloS one.

[60]  V. Ganapathy,et al.  Drugs of abuse and human placenta. , 2011, Life sciences.

[61]  Michael Fitzgerald,et al.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD , 2010, BMC psychiatry.

[62]  W. Jones,et al.  Drugs and breastfeeding. , 2010, Community practitioner : the journal of the Community Practitioners' & Health Visitors' Association.

[63]  L. Scahill.  Alpha-2 Adrenergic Agonists in Children with Inattention, Hyperactivity and Impulsiveness , 2009, CNS Drugs.

[64]  A. Bartu,et al.  Transfer of methylamphetamine and amphetamine into breast milk following recreational use of methylamphetamine. , 2009, British journal of clinical pharmacology.

[65]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[66]  E. Sonuga-Barke,et al.  Do maternal attention-deficit/hyperactivity disorder symptoms exacerbate or ameliorate the negative effect of child attention-deficit/hyperactivity disorder symptoms on parenting? , 2008, Development and Psychopathology.

[67]  M. Papoušek.  Communication in early infancy: an arena of intersubjective learning. , 2007, Infant behavior & development.

[68]  K. Ilett,et al.  Transfer of dexamphetamine into breast milk during treatment for attention deficit hyperactivity disorder. , 2007, British journal of clinical pharmacology.

[69]  O. Spigset,et al.  Excretion of methylphenidate in breast milk. , 2007, The American journal of psychiatry.

[70]  K. Ilett,et al.  Methylphenidate and Breast-Feeding , 2006, The Annals of Pharmacotherapy.

[71]  Robert Plomin,et al.  Chaos in the home and socioeconomic status are associated with cognitive development in early childhood: Environmental mediators identified in a genetic design. , 2004 .

[72]  K. Perry,et al.  Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder , 2002, Neuropsychopharmacology.

[73]  Jules R Altfas.  Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment , 2002, BMC psychiatry.

[74]  E. Sonuga-Barke,et al.  Does maternal ADHD reduce the effectiveness of parent training for preschool children's ADHD? , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

[75]  S. Nicolaidis,et al.  Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats , 2001, Neuroreport.

[76]  R. Ariagno,et al.  Methamphetamine ingestion by a breast-feeding mother and her infant's death: People v Henderson. , 1995, JAMA.

[77]  A. Matheny,et al.  Bringing order out of chaos: Psychometric characteristics of the confusion, hubbub, and order scale , 1995 .

[78]  Lisa S. Wolff,et al.  The Parenting Scale: A measure of dysfunctional parenting in discipline situations. , 1993 .

[79]  C. Johnston,et al.  A Measure of Parenting Satisfaction and Efficacy , 1989 .

[80]  E. Philipp.  Guanfacine in the treatment of hypertension due to pre-eclamptic toxaemia in thirty women. , 1980, British journal of clinical pharmacology.

[81]  J. Buitelaar,et al.  The Reciprocal Relationship of ASD, ADHD, Depressive Symptoms and Stress in Parents of Children with ASD and/or ADHD , 2014, Journal of autism and developmental disorders.

[82]  A. Berger,et al.  Prediction of Preschool Aggression from DRD4 Risk, Parental ADHD Symptoms, and Home Chaos , 2014, Journal of abnormal child psychology.

[83]  A. Yamatodani,et al.  Action of modafinil through histaminergic and orexinergic neurons. , 2012, Vitamins and hormones.

[84]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.

[85]  S. Marcus.  Depression during pregnancy: rates, risks and consequences--Motherisk Update 2008. , 2009, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

[86]  John-Michael Sauer,et al.  Clinical Pharmacokinetics of Atomoxetine , 2005, Clinical pharmacokinetics.

[87]  T. Villén,et al.  Amphetamine secretion in breast milk , 2004, European Journal of Clinical Pharmacology.

[88]  K. Rice,et al.  Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin , 2001, Synapse.

[89]  M. Papoušek,et al.  Biological basis of social interactions: implications of research for an understanding of behavioural deviance. , 1983, Journal of child psychology and psychiatry, and allied disciplines.